The SM Journey: Living
Find out what’s new and what’s next in treatment options for SM.
-
-
HT-KIT receives FDA Orphan Drug Designation for SM
-
FDA grants Breakthrough Designation to bezuclastinib for nonadvanced SM
-
My 2-year journey to getting disability for indolent SM
-
How to store your systemic mastocytosis medications
-
SM without skin involvement may mean higher anaphylaxis risk
-
How does systemic mastocytosis impact the brain?
